Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05146024 · ClinicalTrials.gov registry record
WayToServePlus: Improving Responsible Alcohol Service Ph I
A clinical trial, sponsored by Klein Buendel.
- Completed
- Registry status
- 183
- Enrollment target
NCT05146024: Completed study, sponsored by Klein Buendel.
NCT05146024 is a clinical trial that has completed, run by Klein Buendel. The registered enrollment target is 183 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05146024 has completed, sponsored by Klein Buendel.
- COMPLETED
- Registry status
- 183 participants
- Enrollment target
Study Summary
Responsible beverage service (RBS) training for alcohol servers is a promising intervention for reducing driving while intoxicated (DWI) by alcohol. Training, certification, and in-service contact improves professionalism and effectiveness of prevention interventions delivered by community members such as alcohol servers. This SBIR Fast-track project will develop and test an in-service professional development component to the WayToServe® online RBS training to improve the effectiveness of RBS training in order to make further gains in reducing problem alcohol behavior in communities.
Primary Outcome
Focus Groups, Semi-structured Interviews, Field Pilot Test
Interventions
- BEHAVIORAL Way To Serve Plus: Improving Responsible Alcohol Service
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 183 participants |
| Start Date | 2021-11-10 |
| Est. Completion | 2022-06-30 |
What the finished NCT05146024 record still lists
NCT05146024 is an observational study that tracks outcomes without assigning an intervention. The registered 183 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Way To Serve Plus: Improving Responsible Alcohol Service is the first listed.
NCT05146024 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05146024 about?
NCT05146024 is a clinical study titled "WayToServePlus: Improving Responsible Alcohol Service Ph I". Responsible beverage service (RBS) training for alcohol servers is a promising intervention for reducing driving while intoxicated (DWI) by alcohol. Training, certification, and in-service contact improves professionalism and effectiveness of prevention interventions delivered by community members s...
What is the current status of trial NCT05146024?
This trial is currently completed. The enrollment target is 183 participants. The study started on 2021-11-10. Estimated completion is 2022-06-30.
What interventions are being tested in trial NCT05146024?
The interventions under investigation include: Way To Serve Plus: Improving Responsible Alcohol Service (BEHAVIORAL).
Who is sponsoring clinical trial NCT05146024?
This trial is sponsored by Klein Buendel, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03859297 · 183 participants · NA
Mechanisms of Rumination Change in Adolescent Depression
- NCT04270591 · 183 participants · Phase 1
Assessment of Anti-tumor and Safety in Glumetinib in Patients With c-MET-positive Non-Small Cell Lung Cancer
- NCT06764615 · 183 participants · Phase 2
A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- NCT06872684 · 183 participants · NA
Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI